PPCB logo

PPCB
Propanc Biopharma Inc

1,294
Mkt Cap
$2.15M
Volume
1.82M
52W High
$11.00
52W Low
$0.095
PE Ratio
-0.01
PPCB Fundamentals
Price
$0.103
Prev Close
$0.1004
Open
$0.1034
50D MA
$0.1627
Beta
0.00
Avg. Volume
2.22M
EPS (Annual)
-$14.85
P/B
0.13
Rev/Employee
$0.00
$18.38
Loading...
Loading...
News
all
press releases
News Placeholder
When Wall Street Rotates, Biotech Innovators Emerge: The Untapped Opportunities in Oncology
Market rotations are as old as Wall Street itself. When capital exits overheated sectors like big tech, it often finds its way into undervalued industries ripe for rediscovery. The latest shift, away from pricey artificial intelligence and semiconductor stocks, has once again turned investors’ attention toward biotechnology. And within biotech, the most compelling breakthroughs are not in computing or automation, but in humanity’s longest-standing battle: defeating cancer.As institutional money seeks new opportunities, healthcare and biotech have emerged as natural ...
AllPennyStocks·4mo ago
News Placeholder
When Wall Street Rotates, Biotech Innovators Emerge: The Untapped Opportunities in Oncology
Market rotations are as old as Wall Street itself. When capital exits overheated sectors like big tech, it often finds its way into undervalued industries ripe for rediscovery. The latest shift, away from pricey artificial intelligence and semiconductor stocks, has once again turned investors’ attention toward biotechnology. And within biotech, the most compelling breakthroughs are not in computing or automation, but in humanity’s longest-standing battle: defeating cancer.As institutional money seeks new opportunities, healthcare and biotech have emerged as natural ...
AllPennyStocks·4mo ago
News Placeholder
When Wall Street Rotates, Biotech Innovators Emerge: The Untapped Opportunities in Oncology
Market rotations are as old as Wall Street itself. When capital exits overheated sectors like big tech, it often finds its way into undervalued industries ripe for rediscovery. The latest shift, away from pricey artificial intelligence and semiconductor stocks, has once again turned investors’ attention toward biotechnology. And within biotech, the most compelling breakthroughs are not in computing or automation, but in humanity’s longest-standing battle: defeating cancer.As institutional money seeks new opportunities, healthcare and biotech have emerged as natural ...
AllPennyStocks·4mo ago
News Placeholder
Why Propanc stock Is Tumbling In Premarket Today
The biotech firm announced a $4 million share sale alongside its Nasdaq uplisting, sending trading volumes surging to record levels.
Stocktwits·8mo ago
<
...
1
>

Latest PPCB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.